Literature DB >> 31672303

Treatment of Adrenocortical Carcinoma.

Anand Vaidya1, Matthew Nehs2, Kerry Kilbridge3.   

Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. ACC is capable of secreting excess adrenocortical hormones, which can compound morbidity and compromise clinical outcomes. By the time most ACCs are diagnosed, there is usually locoregional or metastatic disease. Surgery is the most important treatment to offer possibility of cure or prolong survival. Several adjuvant therapies are used depending on grade and stage of the tumor and other patient-related factors. This review provides an overview of treatment approaches for ACC, highlighting evidence to support each treatment and acknowledging where more data and research are needed to improve care.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenal; Adrenal cortex; Adrenocortical carcinoma; Cancer; Mitotane

Mesh:

Year:  2019        PMID: 31672303     DOI: 10.1016/j.path.2019.08.010

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  12 in total

1.  Development and validation of prognostic nomograms in patients with adrenocortical carcinoma: a population-based study.

Authors:  Hao Zhang; Yaser Naji; Minbo Yan; Wenfei Lian; Maochun Xie; Yingbo Dai
Journal:  Int Urol Nephrol       Date:  2020-02-18       Impact factor: 2.370

Review 2.  What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics.

Authors:  C Christofer Juhlin; Ozgur Mete; Jérôme Bertherat; Thomas J Giordano; Gary D Hammer; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2021-02-03       Impact factor: 3.943

3.  Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels.

Authors:  Xiaozeng Lin; Yan Gu; Yingying Su; Ying Dong; Pierre Major; Anil Kapoor; Damu Tang
Journal:  Cancers (Basel)       Date:  2022-06-05       Impact factor: 6.575

4.  Giant androgen-producing adrenocortical carcinoma with atrial flutter: A case report and review of the literature.

Authors:  Mircea-Florin Costache; Raluca-Elena Arhirii; Simona-Juliette Mogos; Corina Lupascu-Ursulescu; Cezara-Ioana Litcanu; Adi-Ionut Ciumanghel; Catalina Cucu; Cristina-Mihaela Ghiciuc; Antoniu-Octavian Petris; Nicolae Danila
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 5.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

6.  Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors.

Authors:  Kai Li; Haiqing Luo; Hui Luo; Xiao Zhu
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

7.  Rare Tumors of the Abdomen in Children.

Authors:  Lung-Huang Lin
Journal:  J Med Ultrasound       Date:  2020-08-10

Review 8.  Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers.

Authors:  Yuling Cheng; Wei Kou; Dandan Zhu; Xinbo Yu; Yu Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555

9.  Ferroptosis-based molecular prognostic model for adrenocortical carcinoma based on least absolute shrinkage and selection operator regression.

Authors:  Chen Lin; Ruofei Hu; FangFang Sun; Weiwei Liang
Journal:  J Clin Lab Anal       Date:  2022-05-02       Impact factor: 3.124

Review 10.  The RING finger protein family in health and disease.

Authors:  Chunmei Cai; Yan-Dong Tang; Jingbo Zhai; Chunfu Zheng
Journal:  Signal Transduct Target Ther       Date:  2022-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.